Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 3:49 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1009–1032 of 8,689 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Longitudinal Studies Clear all

Conditions: Major Depressive Disorder
Interventions: Assay-guided treatment (AGT), Treatment-as-usual (TAU); Genetic · Other
Lead sponsor: Genomind, LLC; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 305 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 23
States / cities: Birmingham, Alabama • Phoenix, Arizona • Springdale, Arkansas + 20 more

Conditions: Hearing Loss
Interventions: Abbreviated Profile Hearing Aid Benefit (APHAB), Glasgow Benefit Inventory (GBI), Additional follow-up visit; Other
Lead sponsor: Oticon Medical; Industry
Eligibility: 18 Years and older
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 6
States / cities: Sarasota, Florida • Indianapolis, Indiana • New York, New York + 3 more

Conditions: Ovarian Cancer, Epithelial, Peritoneal Cancer, Fallopian Tube Cancer
Interventions: Streamlined Education, Traditional Education; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Nurse, in Northern New Jersey, Providing Care to Adults With Covid-19
Interventions: Qualitative (interviews); Other
Lead sponsor: Atlantic Health System; Other
Eligibility: 18 Years to 80 Years
Enrollment: 41 participants
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Morristown, New Jersey

Conditions: Perioperative Nutrition
Interventions: Clear Liquids, Standard of Care; Other
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Abdominal Aortic Aneurysm Without Rupture
Interventions: Nellix® System; Device
Lead sponsor: Endologix; Industry
Eligibility: 18 Years and older
Enrollment: 98 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2025
U.S. locations: 27
States / cities: Huntsville, Alabama • Los Angeles, California • San Diego, California + 24 more

Conditions: Benign Prostatic Hyperplasia (BPH)
Interventions: AQUABEAM System, Transurethral Resection of the Prostate (TURP); Device · Procedure
Lead sponsor: PROCEPT BioRobotics; Industry
Eligibility: 45 Years to 80 Years · Male only
Enrollment: 184 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2021
U.S. locations: 12
States / cities: Birmingham, Alabama • La Mesa, California • Los Angeles, California + 9 more

Conditions: REM Behavior Disorder, Parkinsonism
Interventions: Rozerem, Placebo; Drug
Lead sponsor: Northwestern University; Other
Eligibility: Not listed
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Preparation for Colonoscopy
Interventions: Not listed
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 53 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2006
U.S. locations: 1
States / cities: Scottsdale, Arizona

Conditions: Neuropathic Diabetic Ulcer - Foot
Interventions: RedDress Wound Care System (RD1); Device
Lead sponsor: RedDress Ltd.; Industry
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 4
States / cities: Miami, Florida • North Miami Beach, Florida • Pittsburgh, Pennsylvania + 1 more

Conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder, Psychotic Disorders, Bipolar Disorder
Interventions: PGx testing guided treatment (PGT); Biological
Lead sponsor: Northwell Health; Other
Eligibility: 15 Years to 64 Years
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Glen Oaks, New York

Conditions: Hemorrhagic Stroke, Aneurysm, Intracranial, Saccular Aneurysm, Fusiform Aneurysm, Brain Aneurysm
Interventions: Flow diversion; Device
Lead sponsor: phenox Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 214 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2032
U.S. locations: 25
States / cities: Phoenix, Arizona • Los Angeles, California • San Francisco, California + 21 more

Conditions: Shoulder Dislocation
Interventions: Not listed
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: Fresno, California

Conditions: Mammoplasty Patient
Interventions: Questionnaire Administration, Reconstructive Surgery; Other · Procedure
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Biliary Atresia
Interventions: Filgrastim; Drug
Lead sponsor: Holterman, Ai-Xuan, M.D.; Individual
Eligibility: 14 Days to 180 Days
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Diabetic Foot Ulcer
Interventions: Tenex TXB MicroTip Ultrasound system plus SOC, Standard of Care for diabetic foot ulcer; Device · Other
Lead sponsor: Tenex Health Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 148 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 2
States / cities: Mobile, Alabama • St. George, Utah

Conditions: Benign Prostatic Hyperplasia
Interventions: GreenLight HPS; Device
Lead sponsor: American Medical Systems; Industry
Eligibility: 45 Years and older · Male only
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2013
U.S. locations: 9
States / cities: Los Angeles, California • Middlebury, Connecticut • Roswell, Georgia + 6 more

Conditions: Osteoarthritis, Knee
Interventions: Platelet-rich Plasma (PRP), Hyaluronic Acid; Biological
Lead sponsor: Rush University Medical Center; Other
Eligibility: 18 Years to 80 Years
Enrollment: 111 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Knee Osteoarthritis
Interventions: Minimally invasive total knee replacement, Standard approach total knee replacement; Procedure
Lead sponsor: Mayo Clinic; Other
Eligibility: 45 Years to 75 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Smallpox
Interventions: Not listed
Lead sponsor: Emergent BioSolutions; Industry
Eligibility: 17 Years and older
Enrollment: 14,108 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2015
U.S. locations: 4
States / cities: Twentynine Palms, California • Fort Campbell North, Kentucky • Fort Bliss, Texas + 1 more

Conditions: Myelofibrosis
Interventions: Hematopoietic Stem Cell Transplant; Other
Lead sponsor: Center for International Blood and Marrow Transplant Research; Network
Eligibility: 55 Years and older
Enrollment: 650 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2027
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: X-linked Myotubular Myopathy
Interventions: Not listed
Lead sponsor: Astellas Gene Therapies; Industry
Eligibility: Up to 3 Years · Male only
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 4
States / cities: Los Angeles, California • Gainesville, Florida • Chicago, Illinois + 1 more

Conditions: Neuroblastoma
Interventions: 18F-MFBG; Drug
Lead sponsor: Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC); Industry
Eligibility: Not listed
Enrollment: 43 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 8
States / cities: Los Angeles, California • San Francisco, California • Indianapolis, Indiana + 5 more

Conditions: Myopia
Interventions: MEL 80 Treatment of High Myopia; Device
Lead sponsor: Carl Zeiss Meditec, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 129 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2009
U.S. locations: 5
States / cities: San Diego, California • Greenwood Village, Colorado • Kansas City, Missouri + 2 more

Search by objective public record fields.

Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD

Multi-Center Study on Performance of the Ponto Implant System Using Minimally Invasive Ponto Surgery (in Adult Patients)

Prospective Randomized Trial of Streamlined Genetic Education and Testing for Ovarian Cancer Patients

Nurses Caring for Patients With Covid-19

Clears On the Day of Anesthesia Permissible up to One-Hour Prior (CODA-POP) to Surgery

EVAS2 IDE Prospective, Multicenter, Single Arm Safety and Effectiveness Confirmatory Study

Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)

Efficacy and Tolerability of Ramelteon in Patients With Rapid Eye Movement (REM) Behavior Disorder and Parkinsonism

Patient Preference With Visicol Tablet Preparation for Colonoscopy

Safety Trial of the RedDress Wound Care System (RD1) in Management of Texas 1a or 2a Neuropathic Diabetic Foot Ulcers.

Prospective Pharmacogenetic Testing and Clinical Outcomes in Patients With Early-Phase Psychosis

The Use of p48/64 MW HPC Flow Modulation Device in the Treatment of Wide-necked Intracranial Aneurysms

Anterior Shoulder Dislocation

REVOLVE or PureGraft Technique in Processing Fat Grafts for Patients Undergoing Breast Reconstruction

Part II: Granulocyte-Colony Stimulating Factor Adjunct Therapy for Biliary Atresia

Prospective, Multicenter, RCT of the Tenex Ultrasound System

A Long-Term Study Examining the Treatment of Benign Prostatic Hyperplasia With Photoselective Vaporization

Hyaluronic Acid vs Platelet Rich Plasma: Effects on Clinical Outcomes and Intra-articular Biology for the Treatment of Knee Osteoarthritis

Minimally Invasive Surgical Approaches In Total Knee Arthroplasty

Safety Surveillance Cohort Study of Vaccinia Vaccine (ACAM2000®)

Prospective Assessment of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis

A Clinical Assessment Study in X-Linked Myotubular Myopathy (XLMTM) Subjects

Open-Label Study of 18F-mFBG for Imaging Neuroblastoma

Study of the MEL 80 Excimer Laser Using LASIK in the Treatment of Moderate to High Myopia